Scale Management’s Horizon Therapeutics HZNP Stock Holding History
Bought
Maintained
Sold
Other funds holding HZNP
KCM
Scale Management's HZNP Position: Q3 2016 in Review
Scale Management held its Horizon Therapeutics (HZNP) position steady in Q3 2016 at 1,710,451 shares worth $31M. The position accounts for 68.19% of the portfolio, ranked #1.
Scale Management first reported a position in HZNP in Q4 2014 and has held it in 8 quarters since. The position peaked at $59.4M in Q2 2015. 233 funds tracked by Wall St. Rank hold HZNP as of Q3 2016.
- Scale Management held 1,710,451 shares of Horizon Therapeutics worth $31M as of Q3 2016.
- Scale Management left its Horizon Therapeutics share count unchanged in Q3 2016.
- Horizon Therapeutics made up 68.19% of Scale Management's portfolio in Q3 2016, its #1 holding.
- Scale Management first reported a position in Horizon Therapeutics in Q4 2014 and has held it in 8 quarters since.
- Scale Management's Horizon Therapeutics position peaked at $59.4M in Q2 2015.
- 233 funds tracked by Wall St. Rank held Horizon Therapeutics as of Q3 2016.
Based on Scale Management's 13F filing for Q3 2016, filed 14 Nov 2016.